This study is closed and no longer accepting participants.

Clinical Trial for Leo with photo of Young black woman scratching her shoulder

You’re invited to participate in an exciting clinical trial opportunity for the atopic dermatitis community. Leo Pharma is running a phase 2 trial to evaluate the safety and effectiveness of an orally-administered tablet.

In order to qualify, you must be:

  • Diagnosed with atopic dermatitis (eczema)
  • 18 years or older
  • Living in the U.S. or Australia
  • Willing to take an oral tablet for up to 4 months

Please note that all study-related costs, including those associated with travel to the study clinic, will be reimbursed – you can speak with your site coordinator to learn more about the details.